To assess the effect of hemodialysis on protein metabolism, leucine flux was measured in seven patients before, during, and after high efficiency hemodialysis using cuprophane dialyzers and bicarbonate dialysate during a primed-constant infusion of L-I1-'3CIleucine. The kinetics ;Lsmol/kg per h, mean±SDJ are as follows: leucine appearance into the plasma leucine pool was 86±28, 80±28, and 85±25, respectively, before, during, and after dialysis. Leucine appearance into the whole body leucine pool, derived from plasma l1-'3Cla-ketoisocaproate enrichment, was 118±31, 118±31, and 114±28 before, during, and after dialysis, respectively. In the absence of leucine intake, appearance rate reflects protein degradation, which was clearly unaffected by dialysis. Leucine oxidation rate was 17.3±7.8 before, decreased to 13.8±7.8 during, and increased to 18.9±10.3 after dialysis (P = 0.027). Leucine protein incorporation was 101±26 before, was reduced to 89±23 during, and returned to 95±23 after dialysis (P = 0.13). Leucine net balance, the difference between leucine protein incorporation and leucine release from endogenous degradation, was -173±7.8 before, decreased to -28.5±11.0 during, and returned to -18.9±10.3 after dialysis (P < 0.0001). This markedly more negative leucine balance during dialysis was accountable by dialysate leucine loss, which was 14.4±6.2 umol/kg per h. These data suggest that hemodialysis using a cuprophane membrane did not acutely induce protein degradation. It was, nevertheless, a net catabolic event because protein synthesis was reduced and amino acid was lost into the dialysate. (J. Clin. Invest. 1993 91:2429-2436